Exosome-based Cell Homing and Lineage-Specific Differentiation Strategies for Dental Pulp Regeneration

基于外泌体的牙髓再生细胞归巢和谱系特异性分化策略

基本信息

  • 批准号:
    10450657
  • 负责人:
  • 金额:
    $ 15.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-14 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

[PROJECT SUMMARY/ABSTRACT] Current endodontic therapy for dental caries, which are one of the most prevalent infectious diseases in the world, is a procedure for replacing the vital pulp with synthetic pulp-capping materials. Pulpless teeth can lose their functions to sense environmental changes and maintain dentin regeneration, and the synthetic materials have several disadvantages such as bacterial leakage into the dental pulp, poor cohesive strength, discoloration of tooth, and long setting time. As an alternative, vital pulp therapy (VPT), which is defined as a restorative dental treatment that aims to preserve and maintain pulp tissue, is beneficial for young patients who have high healing capacity for pulp regeneration. Potential for successful VPT and pulp regeneration is increasing due to the knowledge of mesenchymal stem cells (MSCs) that can differentiate into specialized cells. However, the transplantation of MSCs incurs high costs and risks associated with the ex vivo cell expansion. Consequently, a cell homing strategy which recruits endogenous dental pulp stem cells (DPSCs) is the effective approach in endodontics. Recently, exosomes have attracted attention due to their great potential to promote intercellular communication leading to enhanced cell recruitment, differentiation to specific cell lineage, and tissue regeneration. In particular, conditioned medium or exosomes cultured under lineage-specific differentiation have a great potential for angiogenesis and odontogenesis for pulp regeneration. The long-term goal is to develop a pulp capping material system for vital pulp therapy of human dental pulp. The overall objectives for this application are (1) to elucidate the therapeutic potential of characterized exosomes as a chemoattractant to stimulate DPSC migration and pulp-like differentiation and (2) to determine their in vivo effect of pulp regeneration in a rabbit partial pulpotomy model. Our central hypothesis is that exosomes will stimulate dental pulp regeneration by promoting DPSC chemotaxis and lineage-specific differentiation. Exosomes will be isolated from rabbit DPSCs cultured under growth or lineage-specific differentiation conditions (odontogenesis or angiogenesis) and will be encapsulated in injectable hydrogel (F-127/hyaluronic acid) which has temperature-sensitive gelation behavior at body temperature. Specific aims in this proposed study are (1) characterize DPSC-Exos and determine the effect of DPSC-Exos on in vitro cell homing and lineage-specific differentiation and (2) evaluate the in vivo effects of DPSC-Exos on pulp regeneration in a rabbit partial pulpotomy. At the completion of the proposed R03 project, our expected outcomes are to define the therapeutic potential of DPSC-Exos for dental pulp regeneration and to identify miRNAs that may regulate cell homing and pulp tissue formation. These results will have a very important positive impact by providing preliminary data for our future R01 grant application in which we plan to synthesize miRNAs loaded in engineered exosomes, thereby replacing DPSC culture as a potential means of exosome production.
[项目概要/摘要] 目前针对龋齿的牙髓治疗,龋齿是世界上最流行的传染病之一 世界上,是一种用合成盖髓材料代替活髓的程序。无髓牙可能会脱落 它们具有感知环境变化和维持牙本质再生的功能,以及合成材料 存在细菌渗入牙髓、粘结强度差、变色等缺点 齿数多,凝固时间长。作为替代方案,活体牙髓治疗 (VPT) 被定义为一种修复性牙齿治疗方法。 旨在保护和维持牙髓组织的治疗对于愈合率高的年轻患者有益 纸浆再生能力。由于以下原因,成功 VPT 和纸浆再生的潜力正在增加 了解可分化为特化细胞的间充质干细胞 (MSC)。然而, 间充质干细胞移植会产生与离体细胞扩增相关的高成本和风险。因此,一个 招募内源性牙髓干细胞(DPSC)的细胞归巢策略是治疗牙髓病的有效方法。 牙髓病学。近年来,外泌体因其促进细胞间质转化的巨大潜力而​​受到关注。 通讯导致增强细胞募集、分化为特定细胞谱系和组织 再生。特别是,在谱系特异性分化下培养的条件培养基或外泌体具有 血管生成和牙髓再生的巨大潜力。 长期目标是开发一种用于人类牙髓活髓治疗的盖髓材料系统。 该应用的总体目标是(1)阐明特征外泌体的治疗潜力 作为化学引诱剂刺激 DPSC 迁移和牙髓样分化,以及 (2) 确定它们的体内 兔部分活髓切断术模型中牙髓再生的效果。我们的中心假设是外泌体会 通过促进 DPSC 趋化性和谱系特异性分化来刺激牙髓再生。 外泌体将从在生长或谱系特异性分化条件下培养的兔 DPSC 中分离出来 (牙发育或血管生成)并将被封装在可注射水凝胶(F-127/透明质酸)中 在体温下具有温度敏感的凝胶行为。这项研究的具体目标是 (1) 表征 DPSC-Exos 并确定 DPSC-Exos 对体外细胞归巢和谱系特异性的影响 (2) 评估 DPSC-Exos 对兔部分活髓切断术中牙髓再生的体内影响。 在拟议的 R03 项目完成后,我们的预期结果是确定治疗潜力 DPSC-Exos 用于牙髓再生并鉴定可调节细胞归巢和牙髓组织的 miRNA 形成。这些结果将为我们的未来提供初步数据,产生非常重要的积极影响 R01 资助申请,我们计划合成装载在工程外泌体中的 miRNA,从而取代 DPSC 培养作为外泌体生产的潜在手段。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dong Rim Seol其他文献

Dong Rim Seol的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dong Rim Seol', 18)}}的其他基金

Preventive and Therapeutic Effects of Bone Marrow Stem Cell-Derived Exosomes on Spine Dural Fibrosis
骨髓干细胞源性外泌体对脊柱硬膜纤维化的预防和治疗作用
  • 批准号:
    10350148
  • 财政年份:
    2022
  • 资助金额:
    $ 15.26万
  • 项目类别:
Preventive and Therapeutic Effects of Bone Marrow Stem Cell-Derived Exosomes on Spine Dural Fibrosis
骨髓干细胞源性外泌体对脊柱硬膜纤维化的预防和治疗作用
  • 批准号:
    10620150
  • 财政年份:
    2022
  • 资助金额:
    $ 15.26万
  • 项目类别:
Exosome-based Cell Homing and Lineage-Specific Differentiation Strategies for Dental Pulp Regeneration
基于外泌体的牙髓再生细胞归巢和谱系特异性分化策略
  • 批准号:
    10189073
  • 财政年份:
    2021
  • 资助金额:
    $ 15.26万
  • 项目类别:

相似国自然基金

基于呫吨酮的拟肽抗菌剂设计合成、抗菌活性和分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
土壤真菌群落对典型三唑类抗菌剂的抗药性响应特征和机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
二(苯乙烯基)酮类光敏抗菌剂的设计,合成及应用研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
  • 批准号:
    10651432
  • 财政年份:
    2023
  • 资助金额:
    $ 15.26万
  • 项目类别:
Metabolic modulation of Fusobacterium nucleatum virulence
具核梭杆菌毒力的代谢调节
  • 批准号:
    10681729
  • 财政年份:
    2023
  • 资助金额:
    $ 15.26万
  • 项目类别:
Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations
描述肠道微生物群及其衍生代谢物在多种族人群痴呆症发展中的作用
  • 批准号:
    10592025
  • 财政年份:
    2023
  • 资助金额:
    $ 15.26万
  • 项目类别:
Role of non-myeloid cells' pyroptosis in melioidosis
非髓系细胞焦亡在类鼻疽中的作用
  • 批准号:
    10635662
  • 财政年份:
    2023
  • 资助金额:
    $ 15.26万
  • 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 15.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了